Rishon-LeZion, Israel

Adva Cohen

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership. Active years: 2019-2020.


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Adva Cohen: Innovator in Energetic Compounds

Introduction

Adva Cohen is a prominent inventor based in Rishon-LeZion, Israel. She has made significant contributions to the field of energetic compounds, holding 2 patents that showcase her innovative spirit and expertise.

Latest Patents

Cohen's latest patents focus on energetic nitrogen-rich monomers. These are represented by a general formula where each of X1 and X2 is independently NR or a covalent bond. The variable R can be H or C1-4 alkyl. Additionally, T1 and T2 are independently selected from a group consisting of triazole, tetrazole, and guanidine moieties. At least one of T1 and T2 is substituted by a polymerizable group, leading to the development of polymers based on these compounds and their various applications.

Career Highlights

Throughout her career, Adva Cohen has worked with notable organizations, including the Technology Innovation Momentum Fund (Israel) Limited Partnership. Her work in these institutions has allowed her to advance her research and contribute to the field of energetic materials.

Collaborations

Cohen has collaborated with esteemed colleagues such as Michael Gozin and Alex Aizikovich. These partnerships have further enriched her work and expanded her impact in the field.

Conclusion

Adva Cohen is a trailblazer in the development of energetic compounds, with a focus on innovative nitrogen-rich monomers. Her contributions to the field are significant, and her patents reflect her dedication to advancing technology in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…